Posts Tagged: Bayh-Dole
The New Biden Executive Order: Undermining Bayh-Dole is Like Shooting Ourselves in the Foot—Let’s Not Go There
Late Friday, the Biden Administration unveiled what must be one of the longest Executive Orders in history, titled “Promoting Competition in the American Economy.” In 31 pages, it …
The Biden Administration is at an Innovation Crossroad
The new Presidential Administration has hardly settled in before being confronted with a stark choice: will they continue policies that foster public/private sector R&D partnerships …
Stand Up to the Anti-Patent COVID-19 Narrative
It may seem odd, as unprecedented public/private sector R&D alliances work to discover and develop therapies to counter COVID-19, that some are trying to punish …
Everything Depends on Coronavirus R&D Partnerships—Don’t Let the Critics Wreck Them
The world is teetering on the brink of a public health and economic catastrophe, depending on emergency partnerships between our public and private sectors to develop a …
Mad Dash to Coronavirus Vaccine May Face Legal Hurdles
Almost a third of the recently signed $8.3 billion bill to fund the United States response to the coronavirus outbreak is devoted directly to vaccine research and development. …
Bayh-Dole 40: Celebrating the Past, Protecting the Future
It's highly appropriate that the 40th anniversary of the Bayh-Dole Act occurs in a year as politically contentious as that in which it passed. In 1980, many predicted …
Don’t Undermine U.S. Innovation While Standing Up to China
One of the few areas of bipartisan agreement in Washington is that it's time to respond to Chinese economic and military aggression. The need is underscored by …
ITC Investigates University of California Complaint Against Amazon and Other Major Retailers
In late August, the U.S. International Trade Commission published a notice of institution of a Section 337 investigation on behalf of the Regents of the University of …
The ‘Dragon’ Targets U.S. Biopharma Lead
Perhaps the report on China's strategy for eclipsing the U.S. lead in biopharma from the Information Technology & Innovation Foundation (ITIF) resonated so strongly with me because …
Bayh-Dole Rocks While the Critics Play the Same False Note
A just-released study co-sponsored by the Biotechnology Innovation Organization (BIO) and AUTM provides new evidence of the significant contribution academic patent licensing makes to the U.S. …
The One Word that Will Help Restore the U.S. Patent System
Based on the age of many of us in the room, President Reagan was probably the first president many of us remember. And I mention this because …
Jamie Love Responds to Criticism of Knowledge Ecology International Letter
On May 12, Frederick Reinhart published an article titled “Knowledge Ecology International Letter Misleads on March-In Rights.” Reinhart is a past president of the Association of University Technology …
The Washington Post Misses the Mark on March-In Rights
The National Institute of Standards and Technology recently indicated in its "Return on Investment Initiative draft green paper" that it would issue regulations effectively ending attempts to …
If We Don’t Develop Best Practices Ourselves, the Government Will
I recently delivered a keynote address at a special session of the AUTM Annual Meeting, where the Advanced Medical Technology Association (AdvaMed) released its new University Technology …
IP Due Diligence in the Life Sciences: Key Considerations for 2019
The success of a life science product, and thereby the company, rests heavily upon a combination of patent protection, regulatory exclusivity and product life cycle management. A …
